Home › Funds › IQ EQ FUND MANAGEMENT (IRELAND) Ltd › CRSP
IQ EQ FUND MANAGEMENT (IRELAND) Ltd position in CRSP
CRISPR THERAPEUTICS AG · Health Care
IQ EQ FUND MANAGEMENT (IRELAND) Ltd reported holding 391,170 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q3 2026 13F filing — a position valued at US$21.6M, representing 1.33% of its reported portfolio and ranking #17 among its reported holdings. IQ EQ FUND MANAGEMENT (IRELAND) Ltd has disclosed CRSP holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How IQ EQ FUND MANAGEMENT (IRELAND) Ltd's CRSP position evolved
IQ EQ FUND MANAGEMENT (IRELAND) Ltd first disclosed a stake in CRSP in Q2 2024 at 8,708 shares (US$470K). The position peaked in Q3 2026 at 391,170 shares, worth US$21.6M. Across 10 filings, IQ EQ FUND MANAGEMENT (IRELAND) Ltd increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 391,170 shares valued at US$21.6M — an increase of 9,179 shares quarter over quarter.. Notable position changes include a 166% increase in Q4 2024 (shares fell 13% over the following quarter), a 80% increase in Q1 2025 (shares rose 43% over the following quarter), a 200% increase in Q2 2025 (shares rose 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 8.71K | $470.32K | New |
| Q3 2024 | 13.62K | $639.73K | Add |
| Q4 2024 | 36.26K | $1.43M | Add |
| Q1 2025 | 65.19K | $2.22M | Add |
| Q2 2025 | 195.60K | $9.51M | Add |
| Q3 2025 | 283.11K | $18.35M | Add |
| Q4 2025 | 389.52K | $20.43M | Add |
| Q1 2026 | 400.88K | $19.07M | Add |
| Q2 2026 | 381.99K | $20.83M | Reduce |
| Q3 2026 | 391.17K | $21.64M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRSP and 13F data
CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 30 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$556.3M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$144.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRSP
- ARK Invest 10.06M sh · $556.34M · Q3 2026
- Orbis Allan Gray Ltd 5.45M sh · $297.20M · Q2 2026
- GSK plc 2.61M sh · $144.30M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.04M sh · $111.19M · Q2 2026
- Amova Asset Management Americas, Inc. 1.45M sh · $80.36M · Q3 2026
- EcoR1 Capital, LLC 1.39M sh · $75.77M · Q2 2026
- NEA Management Company, LLC 1.06M sh · $57.73M · Q2 2026
More on IQ EQ FUND MANAGEMENT (IRELAND) Ltd
FAQ
How long has IQ EQ FUND MANAGEMENT (IRELAND) Ltd held CRSP?
IQ EQ FUND MANAGEMENT (IRELAND) Ltd has disclosed CRSP holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is IQ EQ FUND MANAGEMENT (IRELAND) Ltd's current position in CRSP?
As of Q3 2026, IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds 391.17K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $21.64M, representing 1.33% of its reported portfolio and ranking #17.
Has IQ EQ FUND MANAGEMENT (IRELAND) Ltd been buying or selling CRSP?
In the latest 13F filing (Q3 2026), IQ EQ FUND MANAGEMENT (IRELAND) Ltd increased its position in CRSP. The position peaked in Q3 2026 at 391.17K shares.
Which other funds hold CRSP?
Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.